About
Male
Michael Kauffman is based out of North Miami Beach, Florida and is the President of Development and Board of Director at Verastem Oncology. Michael previously worked at Nereid Therapeutics as a CEO and President. Michael Kauffman attended the Johns Hopkins University School of Medicine. Michael Kauffman has been certified in Internal Medicine.
Experience
Verastem Oncology
View →Advisor
IPO130Needham, Massachusetts, United StatesBiopharma · Biotechnology
Verastem Oncology
View →President of Development
IPO130Needham, Massachusetts, United StatesBiopharma · Biotechnology
Finance · Financial Services
- Board of Directors · FibroGen2025 – present
- Executive Director, Clio Music & Clio Cannabis · The Clio Awards2018 – present
- Board Member · Kezar Life Sciences2016 – present
- CEO · Karyopharm Therapeutics2011 – present
Education
- Johns Hopkins University School of Medicine · Ph.D., Molecular Biology, Biochemistry– 1992
- Amherst College · Biochemistry
- Johns Hopkins University School of Medicine · MD, Molecular Biology, Biochemistry1985
- Temple University · BA, Communications
Bessemer Venture Partners Portfolio (1)
Verastem Oncology
BiopharmaIPO130 emp
People at Verastem Oncology
Data from: crunchbase
